Skip to content
Brand AI

Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd.

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2022

    Intravacc signs Avacc 3 licensing agreement with Zhifei Lvzhu

    Intravacc signed an exclusive licensing agreement with Beijing Zhifei Lvzhu Biopharmaceutical for its Avacc 3 whooping cough vaccine. Zhifei Lvzhu receives an exclusive license for China and non-exclusive licenses for Africa, South America and selected Asian countries.

    Source